Whilst EU pharma industry flags, Eucomed enjoys a period of relative tranquillity
This article was originally published in RAJ Devices
Executive Summary
Mr Wilkinson maintains that the regulatory environment in Europe makes it generally a good place in which to operate. “It’s not all rosy though, because clearly there are challenges for emerging companies, particularly SMEs [small-to-medium-sized businesses] in terms of raising finance – although I suspect that is a global issue now,” he offers.